Wordt geladen...

Optimized management of advanced hepatocellular carcinoma: Four long-lasting responses to sorafenib

The therapeutic options for hepatocellular carcinoma (HCC) have been so far rather inadequate. Sorafenib has shown an overall survival benefit and has become the new standard of care for advanced HCC. Nevertheless, in clinical practice, some patients are discontinuing this drug because of side effec...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Abbadessa, Giovanni, Rimassa, Lorenza, Pressiani, Tiziana, Carrillo-Infante, Cynthia, Cucchi, Emanuele, Santoro, Armando
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Baishideng Publishing Group Co., Limited 2011
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3103800/
https://ncbi.nlm.nih.gov/pubmed/21633647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v17.i19.2450
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!